AI-generated summary
The authors report a randomized trial of 45 adults with type 2 diabetes and lower-limb peripheral neuropathy, comparing Tecar therapy and low-level laser therapy given separately or together. They found that combined treatment was associated with more lasting improvement in sensory symptoms at three months than either treatment alone, and all three groups improved after 10 sessions.
- Participants
- 45
- Who or what was studied
- Adults aged 51 to 76 years with type 2 diabetes and peripheral sensory neuropathy of the lower limbs
- Limits stated in the abstract
- The abstract does not describe a placebo-controlled design with blinding details, and the sample of 15 per group is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ftrdergisi.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Neuropathy, Low-level laser therapy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.